 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Oxidoreductase
|
PDB id
|
|
|
|
2g1m
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Oxidoreductase
|
 |
|
Title:
|
 |
Cellular oxygen sensing: crystal structure of hypoxia- inducible factor prolyl hydroxylase (phd2)
|
|
Structure:
|
 |
Egl nine homolog 1. Chain: a. Fragment: catalytic domain. Synonym: hypoxia-inducible factor prolyl hydroxylase 2, hif-prolyl hydroxylase 2, hif-ph2, hph-2, prolyl hydroxylase domain-containing protein 2, phd2, sm-20. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: egln1, c1orf12. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
|
|
Resolution:
|
 |
|
2.20Å
|
R-factor:
|
0.216
|
R-free:
|
0.289
|
|
|
Authors:
|
 |
M.A.Mcdonough,C.J.Schofield
|
Key ref:
|
 |
M.A.McDonough
et al.
(2006).
Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2).
Proc Natl Acad Sci U S A,
103,
9814-9819.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
14-Feb-06
|
Release date:
|
13-Jun-06
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
Q9GZT9
(EGLN1_HUMAN) -
Egl nine homolog 1
|
|
|
|
Seq: Struc:
|
 |
 |
 |
426 a.a.
211 a.a.
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.1.14.11.29
- Hypoxia-inducible factor-proline dioxygenase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Hypoxia-inducible factor-L-proline + 2-oxoglutarate + O2 = hypoxia- inducible factor-trans-4-hydroxy-L-proline + succinate + CO2
|
 |
 |
 |
 |
 |
Hypoxia-inducible factor-L-proline
|
+
|
2-oxoglutarate
|
+
|
O(2)
|
=
|
hypoxia- inducible factor-trans-4-hydroxy-L-proline
|
+
|
succinate
|
+
|
CO(2)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
Iron; L-ascorbate
|
 |
 |
 |
 |
 |
Iron
|
L-ascorbate
|
|
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
oxidation-reduction process
|
1 term
|
 |
|
Biochemical function
|
oxidoreductase activity
|
5 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
103:9814-9819
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2).
|
|
M.A.McDonough,
V.Li,
E.Flashman,
R.Chowdhury,
C.Mohr,
B.M.Liénard,
J.Zondlo,
N.J.Oldham,
I.J.Clifton,
J.Lewis,
L.A.McNeill,
R.J.Kurzeja,
K.S.Hewitson,
E.Yang,
S.Jordan,
R.S.Syed,
C.J.Schofield.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Cellular and physiological responses to changes in dioxygen levels in metazoans
are mediated via the posttranslational oxidation of hypoxia-inducible
transcription factor (HIF). Hydroxylation of conserved prolyl residues in the
HIF-alpha subunit, catalyzed by HIF prolyl-hydroxylases (PHDs), signals for its
proteasomal degradation. The requirement of the PHDs for dioxygen links changes
in dioxygen levels with the transcriptional regulation of the gene array that
enables the cellular response to chronic hypoxia; the PHDs thus act as an
oxygen-sensing component of the HIF system, and their inhibition mimics the
hypoxic response. We describe crystal structures of the catalytic domain of
human PHD2, an important prolyl-4-hydroxylase in the human hypoxic response in
normal cells, in complex with Fe(II) and an inhibitor to 1.7 A resolution. PHD2
crystallizes as a homotrimer and contains a double-stranded beta-helix core fold
common to the Fe(II) and 2-oxoglutarate-dependant dioxygenase family, the
residues of which are well conserved in the three human PHD enzymes (PHD 1-3).
The structure provides insights into the hypoxic response, helps to rationalize
a clinically observed mutation leading to familial erythrocytosis, and will aid
in the design of PHD selective inhibitors for the treatment of anemia and
ischemic disease.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. The PHD reaction and an inhibitor. (a) PHD
catalyzed prolyl-4-hydroxylation of HIF- ; one of the oxygens
(red) from the dioxygen cosubstrate is incorporated into proline
to form trans-4-hydroxyproline, and the other is incorporated
into succinate. (b) The structure of compound A.
|
 |
Figure 4.
Fig. 4. Surface representations of PHD2[cat] (a) and
phytanoyl CoA hydroxylase (b) (21) comparing the entrances to
the active site cavities. The surfaces are colored by depth with
a gradient from blue (outermost) to orange (innermost).
|
 |
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Loenarz,
M.L.Coleman,
A.Boleininger,
B.Schierwater,
P.W.Holland,
P.J.Ratcliffe,
and
C.J.Schofield
(2011).
The hypoxia-inducible transcription factor pathway regulates oxygen sensing in the simplest animal, Trichoplax adhaerens.
|
| |
EMBO Rep, 12,
63-70.
|
 |
|
|
|
|
 |
D.Astuti,
C.J.Ricketts,
R.Chowdhury,
M.A.McDonough,
D.Gentle,
G.Kirby,
S.Schlisio,
R.S.Kenchappa,
B.D.Carter,
W.G.Kaelin,
P.J.Ratcliffe,
C.J.Schofield,
F.Latif,
and
E.R.Maher
(2011).
Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility.
|
| |
Endocr Relat Cancer, 18,
73-83.
|
 |
|
|
|
|
 |
C.M.West,
Z.A.Wang,
and
H.van der Wel
(2010).
A cytoplasmic prolyl hydroxylation and glycosylation pathway modifies Skp1 and regulates O2-dependent development in Dictyostelium.
|
| |
Biochim Biophys Acta, 1800,
160-171.
|
 |
|
|
|
|
 |
C.Wotzlaw,
S.Gneuss,
R.Konietzny,
and
J.Fandrey
(2010).
Nanoscopy of the cellular response to hypoxia by means of fluorescence resonance energy transfer (FRET) and new FRET software.
|
| |
PMC Biophys, 3,
5.
|
 |
|
|
|
|
 |
E.Flashman,
L.M.Hoffart,
R.B.Hamed,
J.M.Bollinger,
C.Krebs,
and
C.J.Schofield
(2010).
Evidence for the slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 with oxygen.
|
| |
FEBS J, 277,
4089-4099.
|
 |
|
|
|
|
 |
E.Flashman,
S.L.Davies,
K.K.Yeoh,
and
C.J.Schofield
(2010).
Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
|
| |
Biochem J, 427,
135-142.
|
 |
|
|
|
|
 |
H.S.Kim,
H.L.Kim,
K.H.Kim,
d.o. .J.Kim,
S.J.Lee,
J.Y.Yoon,
H.J.Yoon,
H.Y.Lee,
S.B.Park,
S.J.Kim,
J.Y.Lee,
and
S.W.Suh
(2010).
Crystal structure of Tpa1 from Saccharomyces cerevisiae, a component of the messenger ribonucleoprotein complex.
|
| |
Nucleic Acids Res, 38,
2099-2110.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
K.L.Gorres,
and
R.T.Raines
(2010).
Prolyl 4-hydroxylase.
|
| |
Crit Rev Biochem Mol Biol, 45,
106-124.
|
 |
|
|
|
|
 |
M.A.Culpepper,
E.E.Scott,
and
J.Limburg
(2010).
Crystal structure of prolyl 4-hydroxylase from Bacillus anthracis.
|
| |
Biochemistry, 49,
124-133.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
N.R.Rose,
E.C.Woon,
G.L.Kingham,
O.N.King,
J.Mecinović,
I.J.Clifton,
S.S.Ng,
J.Talib-Hardy,
U.Oppermann,
M.A.McDonough,
and
C.J.Schofield
(2010).
Selective inhibitors of the JMJD2 histone demethylases: combined nondenaturing mass spectrometric screening and crystallographic approaches.
|
| |
J Med Chem, 53,
1810-1818.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
O.Weinreb,
T.Amit,
S.Mandel,
L.Kupershmidt,
and
M.B.Youdim
(2010).
Neuroprotective multifunctional iron chelators: from redox-sensitive process to novel therapeutic opportunities.
|
| |
Antioxid Redox Signal, 13,
919-949.
|
 |
|
|
|
|
 |
S.Nagel,
N.P.Talbot,
J.Mecinović,
T.G.Smith,
A.M.Buchan,
and
C.J.Schofield
(2010).
Therapeutic manipulation of the HIF hydroxylases.
|
| |
Antioxid Redox Signal, 12,
481-501.
|
 |
|
|
|
|
 |
C.E.Charron,
P.C.Chou,
D.J.Coutts,
V.Kumar,
M.To,
K.Akashi,
L.Pinhu,
M.Griffiths,
I.M.Adcock,
P.J.Barnes,
and
K.Ito
(2009).
Hypoxia-inducible factor 1alpha induces corticosteroid-insensitive inflammation via reduction of histone deacetylase-2 transcription.
|
| |
J Biol Chem, 284,
36047-36054.
|
 |
|
|
|
|
 |
D.A.Chan,
T.L.Kawahara,
P.D.Sutphin,
H.Y.Chang,
J.T.Chi,
and
A.J.Giaccia
(2009).
Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment.
|
| |
Cancer Cell, 15,
527-538.
|
 |
|
|
|
|
 |
G.L.Semenza
(2009).
Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis.
|
| |
Blood, 114,
2015-2019.
|
 |
|
|
|
|
 |
H.Chen,
and
M.Costa
(2009).
Iron- and 2-oxoglutarate-dependent dioxygenases: an emerging group of molecular targets for nickel toxicity and carcinogenicity.
|
| |
Biometals, 22,
191-196.
|
 |
|
|
|
|
 |
M.K.Koski,
R.Hieta,
M.Hirsilä,
A.Rönkä,
J.Myllyharju,
and
R.K.Wierenga
(2009).
The crystal structure of an algal prolyl 4-hydroxylase complexed with a proline-rich peptide reveals a novel buried tripeptide binding motif.
|
| |
J Biol Chem, 284,
25290-25301.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Kaczmarek,
R.E.Cachau,
I.A.Topol,
K.S.Kasprzak,
A.Ghio,
and
K.Salnikow
(2009).
Metal Ions-Stimulated Iron Oxidation in Hydroxylases Facilitates Stabilization of HIF-1{alpha} Protein.
|
| |
Toxicol Sci, 107,
394-403.
|
 |
|
|
|
|
 |
O.Aprelikova,
S.Pandolfi,
S.Tackett,
M.Ferreira,
K.Salnikow,
Y.Ward,
J.I.Risinger,
J.C.Barrett,
and
J.Niederhuber
(2009).
Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response.
|
| |
Cancer Res, 69,
616-624.
|
 |
|
|
|
|
 |
R.Chowdhury,
M.A.McDonough,
J.Mecinović,
C.Loenarz,
E.Flashman,
K.S.Hewitson,
C.Domene,
and
C.J.Schofield
(2009).
Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases.
|
| |
Structure, 17,
981-989.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Barth,
F.Edlich,
U.Berchner-Pfannschmidt,
S.Gneuss,
G.Jahreis,
P.A.Hasgall,
J.Fandrey,
R.H.Wenger,
and
G.Camenisch
(2009).
Hypoxia-inducible factor prolyl-4-hydroxylase PHD2 protein abundance depends on integral membrane anchoring of FKBP38.
|
| |
J Biol Chem, 284,
23046-23058.
|
 |
|
|
|
|
 |
S.Leitgeb,
G.D.Straganz,
and
B.Nidetzky
(2009).
Functional characterization of an orphan cupin protein from Burkholderia xenovorans reveals a mononuclear nonheme Fe2+-dependent oxygenase that cleaves beta-diketones.
|
| |
FEBS J, 276,
5983-5997.
|
 |
|
|
|
|
 |
T.D.Bugg
(2009).
Oxygenases get to grips with polypeptides.
|
| |
Structure, 17,
913-914.
|
 |
|
|
|
|
 |
V.I.Bunik,
and
A.R.Fernie
(2009).
Metabolic control exerted by the 2-oxoglutarate dehydrogenase reaction: a cross-kingdom comparison of the crossroad between energy production and nitrogen assimilation.
|
| |
Biochem J, 422,
405-421.
|
 |
|
|
|
|
 |
Z.Shao,
Y.Zhang,
and
J.A.Powell-Coffman
(2009).
Two distinct roles for EGL-9 in the regulation of HIF-1-mediated gene expression in Caenorhabditis elegans.
|
| |
Genetics, 183,
821-829.
|
 |
|
|
|
|
 |
B.Bleijlevens,
T.Shivarattan,
E.Flashman,
Y.Yang,
P.J.Simpson,
P.Koivisto,
B.Sedgwick,
C.J.Schofield,
and
S.J.Matthews
(2008).
Dynamic states of the DNA repair enzyme AlkB regulate product release.
|
| |
EMBO Rep, 9,
872-877.
|
 |
|
|
|
|
 |
B.M.Lienard,
A.Conejo-García,
I.Stolze,
C.Loenarz,
N.J.Oldham,
P.J.Ratcliffe,
and
C.J.Schofield
(2008).
Evaluation of aspirin metabolites as inhibitors of hypoxia-inducible factor hydroxylases.
|
| |
Chem Commun (Camb), 0,
6393-6395.
|
 |
|
|
|
|
 |
F.S.Lee
(2008).
Genetic causes of erythrocytosis and the oxygen-sensing pathway.
|
| |
Blood Rev, 22,
321-332.
|
 |
|
|
|
|
 |
G.H.Fong,
and
K.Takeda
(2008).
Role and regulation of prolyl hydroxylase domain proteins.
|
| |
Cell Death Differ, 15,
635-641.
|
 |
|
|
|
|
 |
J.M.Simmons,
T.A.Müller,
and
R.P.Hausinger
(2008).
Fe(II)/alpha-ketoglutarate hydroxylases involved in nucleobase, nucleoside, nucleotide, and chromatin metabolism.
|
| |
Dalton Trans, 0,
5132-5142.
|
 |
|
|
|
|
 |
J.Mecinović,
R.Chowdhury,
B.M.Liénard,
E.Flashman,
M.R.Buck,
N.J.Oldham,
and
C.J.Schofield
(2008).
ESI-MS studies on prolyl hydroxylase domain 2 reveal a new metal binding site.
|
| |
ChemMedChem, 3,
569-572.
|
 |
|
|
|
|
 |
M.C.Lauzier,
G.A.Robitaille,
D.A.Chan,
A.J.Giaccia,
and
D.E.Richard
(2008).
(2R)-[(4-Biphenylylsulfonyl)amino]-N-hydroxy-3-phenylpropionamide (BiPS), a matrix metalloprotease inhibitor, is a novel and potent activator of hypoxia-inducible factors.
|
| |
Mol Pharmacol, 74,
282-288.
|
 |
|
|
|
|
 |
M.L.Alcaide-German,
A.Vara-Vega,
L.F.Garcia-Fernandez,
M.O.Landazuri,
and
L.del Peso
(2008).
A yeast three-hybrid system that reconstitutes mammalian hypoxia inducible factor regulatory machinery.
|
| |
BMC Cell Biol, 9,
18.
|
 |
|
|
|
|
 |
P.C.Bruijnincx,
G.van Koten,
and
R.J.Klein Gebbink
(2008).
Mononuclear non-heme iron enzymes with the 2-His-1-carboxylate facial triad: recent developments in enzymology and modeling studies.
|
| |
Chem Soc Rev, 37,
2716-2744.
|
 |
|
|
|
|
 |
R.Chowdhury,
A.Hardy,
and
C.J.Schofield
(2008).
The human oxygen sensing machinery and its manipulation.
|
| |
Chem Soc Rev, 37,
1308-1319.
|
 |
|
|
|
|
 |
X.Y.Li,
C.Takasaki,
Y.Satoh,
S.Kimura,
K.Yasumoto,
and
K.Sogawa
(2008).
Expression, purification and characterization of human PHD1 in Escherichia coli.
|
| |
J Biochem, 144,
555-561.
|
 |
|
|
|
|
 |
A.Ozer,
and
R.K.Bruick
(2007).
Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one?
|
| |
Nat Chem Biol, 3,
144-153.
|
 |
|
|
|
|
 |
M.J.Percy,
P.W.Furlow,
P.A.Beer,
T.R.Lappin,
M.F.McMullin,
and
F.S.Lee
(2007).
A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove.
|
| |
Blood, 110,
2193-2196.
|
 |
|
|
|
|
 |
T.P.Cash,
Y.Pan,
and
M.C.Simon
(2007).
Reactive oxygen species and cellular oxygen sensing.
|
| |
Free Radic Biol Med, 43,
1219-1225.
|
 |
|
|
|
|
 |
Y.Pan,
K.D.Mansfield,
C.C.Bertozzi,
V.Rudenko,
D.A.Chan,
A.J.Giaccia,
and
M.C.Simon
(2007).
Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro.
|
| |
Mol Cell Biol, 27,
912-925.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|